Abstract

Although recent advances in imaging diagnosis, surgical techniques, and perioperative management can result in increased resectability and improved surgical outcomes, most resected patients still develop cancer recurrence. If patients develop cancer recurrence, their prognosis is very ominous. However, there have been some recent reports to show promising outcomes by aggressive surgical strategy in selected patients who developed cancer recurrence. Because there are various surgical procedures being selected at initial surgery in patients with biliary tract cancers, recurrent patterns after resection are very variable in each patient. However, surgical procedures might usually be very complicated and difficult if re‐surgical resection is considered in patients with recurrent biliary tract cancer, Therefore, surgical re‐resection could bring about high surgical morbidity and mortality rates in most previously reported series. Although re‐surgical resection might offer a chance of favorable outcome in selected patients with biliary tract cancers, these aggressive surgical approaches should be carried out in strictly selected patients by expert surgeons at high‐volume centers.

Highlights

  • Cholangiocarcinoma can be classified as intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, or distal cholangiocarcinoma according to anatomical location

  • The hilar type of intrahepatic cholangiocarcinoma (ICC) might be involved in perihilar cholangiocarcinoma together with hilar cholangiocarcinoma developed from the hilar extrahepatic bile duct

  • Biliary tract cancer usually recurs after surgical resection, even after curative resection

Read more

Summary

Introduction

Cholangiocarcinoma can be classified as intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma, or distal cholangiocarcinoma according to anatomical location. Surgical resection has been shown to achieve a 3-year survival of 40-50%.7,8 Tan et al.,[9] using SEER Medicare data, identified 3756 patients with ICC, and only 12% underwent cancer-directed surgery.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.